• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂、硫酸长春地辛联合化疗治疗晚期食管癌的疗效

[Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].

作者信息

Akazawa S, Kitagawa H, Nakagawa T, Fujiki T, Kanda Y, Futatsuki K, Sampi K, Fujita K

出版信息

Gan To Kagaku Ryoho. 1984 May;11(5):1018-23.

PMID:6539098
Abstract

Eleven patients with advanced squamous cell carcinoma of the esophagus were treated with a two-drug combination of cis-diammine dichloroplatinum and vindesine sulfate at Saitama Cancer Center between July 1982 and September 1983. Median age was 71 years old (range: 47-48) and 8 patients were greater than 70 years old. Median performance status was 3 (range: 1-4) by Koyama -Saito Criteria. Male female ratio was 6:5. Of the 11 patents, three obtained partial response (27.3%), lasting 8 weeks, 20 weeks+, and 42 weeks-, respectively, and three patients had minor response (27.3%). The major toxic effects including myelosuppression, nausea and vomiting were in general manageable.

摘要

1982年7月至1983年9月间,埼玉癌症中心对11例晚期食管鳞状细胞癌患者采用顺二氯二氨铂和硫酸长春地辛两药联合方案进行治疗。中位年龄为71岁(范围:47 - 88岁),8例患者年龄大于70岁。根据小山-斋藤标准,中位体能状态为3(范围:1 - 4)。男女比例为6:5。11例患者中,3例获得部分缓解(27.3%),缓解持续时间分别为8周、20周以上和42周以下,3例患者有轻微缓解(27.3%)。包括骨髓抑制、恶心和呕吐在内的主要毒性作用总体上是可控的。

相似文献

1
[Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].顺铂、硫酸长春地辛联合化疗治疗晚期食管癌的疗效
Gan To Kagaku Ryoho. 1984 May;11(5):1018-23.
2
Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):781-5.
3
[Combination chemotherapy of nicardipine and vindesine sulfate, cis-diammine dichloroplatinum (II) for patients with advanced esophageal carcinoma].尼卡地平与硫酸长春地辛、顺二氨二氯铂(II)联合化疗治疗晚期食管癌患者
Gan To Kagaku Ryoho. 1984 Apr;11(4):943-7.
4
[Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents for patients with advanced esophageal cancer].
Gan To Kagaku Ryoho. 1985 Jun;12(6):1286-93.
5
A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.一项关于依达曲沙联合长春碱、阿霉素、顺铂和非格司亭(EVAC/G-CSF)用于晚期恶性肿瘤患者的剂量探索性试验:对非小细胞肺癌具有有前景的抗肿瘤活性。
Cancer J Sci Am. 1997 Sep-Oct;3(5):297-302.
6
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.顺铂、阿霉素、环磷酰胺和长春地辛联合化疗治疗非小细胞肺癌。
Cancer Treat Rep. 1982 Feb;66(2):247-51.
7
Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.顺铂、长春地辛、丝裂霉素-C和13-顺式维甲酸治疗晚期非小细胞肺癌。一项II期初步研究。
Anticancer Res. 2000 May-Jun;20(3B):1985-90.
8
Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience.
Anticancer Res. 2005 May-Jun;25(3c):2489-92.
9
Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.在晚期移行细胞癌治疗中,紫杉醇、长春碱和顺铂(PVC)之间存在依时间表而定的有害相互作用的证据。
Br J Cancer. 2000 Dec;83(12):1612-6. doi: 10.1054/bjoc.2000.1480.
10
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.顺铂和依托泊苷联合进行有效放化疗用于治疗局部无法手术及转移性食管癌患者。
Cancer. 1996 Oct 15;78(8):1646-50.